Thermo Fisher Scientific (TMO) Volatility
Healthcare
Market data as of 2026-09-04 · Autonium metric computed 2026-09-04 · model v1TMO volatility — the short answer
TMO's realised volatility is 23.8% annualised over 20 days and 29.6% over 60 days, placing it in the 29th percentile of its own last year.
Volatility and drawdown
Realised volatility (20d, annualised)+23.8%
Realised volatility (60d, annualised)+29.6%
1-year volatility percentile29
Current drawdown from peak-4.0%
Deepest 1-year drawdown-31.5%
SPY volatility (20d)+8.1%
Signal drivers
MomentumNeutral
Technical trendNeutral
VolatilityNeutral
SentimentNeutral
Sector peers — 20-day volatility
LLY — Eli Lilly and Co.33.1
UNH — UnitedHealth Group19.2
JNJ — Johnson & Johnson21.2
ABBV — AbbVie Inc.21.6
MRK — Merck & Co.49.1
Track TMO inside Autonium
Full factor detail, alerts when the score changes, and Toni to ask why.
Continue analysing TMO
Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.